Earnings Call
May 6, 2026
Q1 FY2026
EPS Estimate
1.19
EPS Actual
1.42
Post-Earnings Close
$151.28
Earnings Reaction
-9.7%
Insulet opened 2026 with its strongest quarterly performance in recent memory, posting total revenues of $762 million, a 34% reported and 30% constant-currency increase, well ahead of consensus expectations. The beat was broad-based: U.S. Omnipod grew 28% (exceeding the high end of guidance even after stripping out a $10 million distributor timing benefit that pulled forward from Q2), while international Omnipod surged 45% on a constant-currency basis, marking the third consecutive quarter above 40% growth. Adjusted EPS of $1.42 rose approximately 40% year-over-year, powered by top-line momentum, 110 basis points of adjusted operating margin expansion, and the accretive effect of $300 million in share repurchases executed during the quarter. Management responded by raising full-year total company revenue growth guidance from 20%-22% to 21%-23%.
Report generated on May 8, 2026
AI-generated earnings analysis. Not investment advice.
Chief Executive Officer
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
The quarter's results reflected a combination of company-specific execution and broader sector dynamics, with management addressing several of the key debates that analysts had flagged heading into the print. Guidance commentary pointed to continued momentum in the core segments, while questions on margins and capital allocation drew more nuanced responses from the leadership team over the course of the call.
Read the full PODD analysis
The complete report, with key themes, analyst Q&A summary, notable quotes, and market context — is free with an account. No password, no card.